According to the report published by Allied Market Research, the global opioids use disorder market was estimated at $2.8 billion in 2021 and is expected to hit $8.1 billion by 2031, registering a CAGR of 11.5% from 2022 to 2031. The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and evolving market trends. The market study is a helpful source of information for the frontrunners, new entrants, investors, and shareholders in crafting strategies for the future and heightening their position in the market.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/12668
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2022Ββ2031 |
| Base Year | 2021 |
| Market Size in 2021 | $2.8 Billion |
| Market Size in 203 | $8.1 Billion |
| CAGR | 11.5% |
| No. of Pages in Report | 324 |
| Segments Covered | Drug Type, Age Group, Route of Administration, Distribution Channel, and Region |
| Drivers | Rise in product launch and product approval for opioid use disorder drugs |
| Growing consideration of buprenorphine patches as an effective treatment mode | |
| Opportunities | Surge in adoption of key strategies such as collaboration, acquisition, agreement, and partnership by the frontrunners in the industry |
| Restraints | Certain side-effects of the opioids use disorder drugs |
Covid-19 scenario-
- A huge number of clinics, hospitals across the globe, were restructured to increase the hospital capacity for the patients diagnosed with Covid-19. Moreover, the postponement or cancellation of doctor appointments affected the global opioids use disorder market severely.
- Drop in the number of scheduled surgeries led to decline in demand for opioids which cause decrease in the prevalence of opioid use disorder.
Get detailed COVID-19 impact analysis on the Opioid Use Disorder Market- https://www.alliedmarketresearch.com/request-for-customization/12668?reqfor=covid
The global opioids use disorder market is analyzed across drug type, age group, route of administration, distribution channel, and region. The report takes in an exhaustive analysis of segments and their sub-segments with the help of tabular and graphical representation. Investors and market players can benefit from the breakdown and devise stratagems based on the highest revenue-generating and fastest-growing segments stated in the report.
Based on drug type, the agonist segment contributed to more than four-fifths of the global opioids use disorder market in 2021 and is expected to dominate by 2031. The same segment would also showcase the fastest CAGR of 11.6% throughout the forecast period.
Based on age group, the 19 to 39 segment held nearly half of the total market revenue in 2021 and is expected to dominate by 2031. The same segment would also manifest the fastest CAGR of 11.9% throughout the forecast period.
Based on route of administration, the intravenous segment held around more than half of the total market revenue in 2021 and is expected to dominate by 2031. The same segment would also cite the fastest CAGR of 11.9% throughout the forecast period.
By distribution channel, the hospital pharmacy segment held nearly three-fourths of the total market revenue in 2021 and is expected to dominate by 2031. The same segment would also project the fastest CAGR of 11.6% throughout the forecast period.
Based on region, the market across North America generated nearly two-fifths of the global opioids use disorder market revenue in 2021 and is anticipated to retain the lionβs share by 2031. Asia-Pacific, on the other hand, would showcase the fastest CAGR of 12.3% during the forecast period. The other regions studied in the report include LAMEA and Europe.
For Purchase Inquiry- https://www.alliedmarketresearch.com/purchase-enquiry/12668
The key market players analyzed in the global opioids use disorder market report include AstraZeneca Plc., BioDelivery Sciences International Inc., Braeburn, Cerebral, Hikma Pharmaceuticals PLC, NYC Health + Hospitals, Dr. Reddy, Indivior PLC, Mallinckrodt Pharmaceuticals, Alkermes, Orexo AB, Camurus, Pear Therapeutics, Pfizer, Reckitt Benckiser Pharmaceuticals Inc., Sandoz (Novartis), Viatris Inc., and Titan Pharmaceuticals, Inc. These market players have embraced several strategies including partnership, expansion, collaboration, joint ventures, and others to highlight their prowess in the industry. The report is helpful in formulating the business performance, product portfolio, operating segments, and developments by the top players.
Official Press Release-Β https://www.alliedmarketresearch.com/press-release/opioid-use-disorder-market.html
πππ‘ππ« ππ«ππ§ππ’π§π πππ©π¨π«ππ¬:
Medical Tourism Marketβββ
https://www.alliedmarketresearch.com/medical-tourism-market
Diabetes Therapeutics Marketβββhttps://www.alliedmarketresearch.com/diabetes-therapeutics-market
Contact us:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1β800β792β5285, +1β503β894β6022
UK: +44β845β528β1300
Hong Kong: +852β301β84916
India (Pune): +91β20β66346060
Fax: +1(855)550β5975
help@alliedmarketresearch.com
About us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of βMarket Research Reportsβ and βBusiness Intelligence Solutions.β AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.